Green Thumb Industries (GTBIF) Non Operating Income (2019 - 2026)
Green Thumb Industries (GTBIF) posted Non Operating Income of $22.4 million for Q1 2026, down 79.51% on a QoQ basis from $109.4 million in Q4 2025, and up 910.01% year-over-year from $2.2 million in Q1 2025.
Green Thumb Industries (GTBIF) Non Operating Income (2019 - 2026) Analysis & Trends
Green Thumb Industries' Non Operating Income history runs 8 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- Quarterly Non Operating Income rose 910.01% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.8 million (up 858.76% YoY) and the FY2025 annual result came in at $125.7 million, up 617.4% from the prior year.
- Non Operating Income was $22.4 million for Q1 2026 at Green Thumb Industries, down from $109.4 million in the prior quarter.
- Across five years, Non Operating Income topped out at $109.4 million in Q4 2025 and bottomed at -$22.1 million in Q4 2023.
- A 5-year average of $4.9 million and a median of -$2.8 million in 2025 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 1338.69% in 2025, while the deepest fall reached 1323.52% in 2025.
- Green Thumb Industries' Non Operating Income stood at -$14.1 million in 2022, then sank by 57.31% to -$22.1 million in 2023, then surged by 41.28% to -$13.0 million in 2024, then surged by 942.04% to $109.4 million in 2025, then plunged by 79.51% to $22.4 million in 2026.
- Business Quant data shows GTBIF's Non Operating Income at $22.4 million in Q1 2026, $109.4 million in Q4 2025, and $36.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 22.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.41 Mn |
| Dec 31, 2025 | 109.36 Mn |
| Sep 30, 2025 | 36.18 Mn |
| Jun 30, 2025 | -17.13 Mn |
| Mar 31, 2025 | -2.77 Mn |
| Dec 31, 2024 | -12.99 Mn |
| Sep 30, 2024 | -2.92 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Mar 31, 2024 | -7.17 Mn |
| Dec 31, 2023 | -22.12 Mn |
| Sep 30, 2023 | -3.69 Mn |
| Jun 30, 2023 | -1.61 Mn |
| Mar 31, 2023 | -1.16 Mn |
| Dec 31, 2022 | -14.06 Mn |
| Sep 30, 2022 | -5.64 Mn |
| Jun 30, 2022 | 808,000.00 |
| Mar 31, 2022 | 6.27 Mn |
| Dec 31, 2021 | -3.93 Mn |
| Sep 30, 2021 | 837,000.00 |
| Jun 30, 2021 | 2.45 Mn |